Mass spectrometry analysis identified the band as AHR (Supplementary Table S3), a transcriptional factor dysregulated in various types of cancer.25 We then validated this interaction between AHR and lncSLCC1 by western blotting following RNA pull-down (Fig. 4c). This evidence concerns the gene AHR and cancer.